ArticleJournal for immunotherapy of cancer2026
Emergence of a mixed CAF population by FAP-CD3 T-cell engager limits therapeutic efficacy.
Robert J Norgard et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it